Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Rituximab and Chlorambucil as Front-Line Treatment in Untreated Follicular Lymphoma: a Combination with a Durable Response and Low Toxicity Profile.

Simona Bassi, MD, Luca Nassi, MD, Giancarlo Pruneri, MD, Simona Sammassimo, MD, Paola Bertazzoni, MD, Federica Gigli, MD, Anna Vanazzi, MD, Emilia Cocorocchio, MD, Patrizia Mancuso, Cristina Rabascio, Maria Teresa Lionetti, Daniele Laszlo, MD, Giovanni Martinelli, MD

Blood (2009) 114 (22): 3754.

https://doi.org/10.1182/blood.V114.22.3754.3754

Published: 2009

Journal Articles

Continuous Immuno-Chemotherapy Followed by High Dose and Autologous Cell Transplantation May Improve the Event-Free-Survival in Mantle Cell Lymphoma Patients. Experience at the European Institute of Oncology in Milan.

Simona Bassi, MD, Alessandra Alietti, MD, Chiara Corsini, DSc, Federica Gigli, MD, Paola Bertazzoni, MD, Cristina Rabascio, DSc, Patrizia Mancuso, DSc, Emilia Cocorocchio, MD, Daniele Laszlo, MD, Giancarlo Pruneri, MD, Lorenzo Preda, MD, Sarah J. Liptrott, BN, Rosaria Cascio, PH, Francesco Bertolini, MD, Giovanni Martinelli, MD

Blood (2007) 110 (11): 5116.

https://doi.org/10.1182/blood.V110.11.5116.5116

Published: 2007

Journal Articles

Efficacy of 90Y-Ibritumomab Tiuxetan in Marginal-Zone Lymphoma (MZL).

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Giancarlo Pruneri, MD, Cristiano Crosta, MD, Antonello Pinto, MD, Marco Chinol, PhD, Giovanni Paganelli, MD, Giovanni Martinelli, MD

Blood (2007) 110 (11): 4499.

https://doi.org/10.1182/blood.V110.11.4499.4499

Published: 2007

Journal Articles

Combined VBM Chemotherapy and Involved Field (IF) Radiotherapy in Early Stage Hodgkin’s Lymphoma (HL): A Single Centre Experience.

Emilia Cocorocchio, MD, Fedro A. Peccatori, MD, Federica Gigli, MD, Simona Bassi, MD, Luca Nassi, MD, Liliana Calabrese, DSc, Laura Travaini, MD, Gaia Piperno, MD, Lorenzo Preda, MD, Giancarlo Pruneri, MD, Sarah J. Liptrott, BN, Alessandra Alietti, MD, Giovanni Martinelli, MD

Blood (2007) 110 (11): 4463.

https://doi.org/10.1182/blood.V110.11.4463.4463

Published: 2007

Journal Articles

Efficacy of 90 Y-Ibritumomab Tiuxetan (Zevalin) in Refractory or Relapsed MALT Gastric Non Hodgkin’s Lymphoma.

Anna Vanazzi, MD, Pier F. Ferrucci, MD, Chiara Grana, MD, Giancarlo Pruneri, MD, Cristiano Crosta, MD, Antonello Pinto, MD, Marco Chinol, Giovanni Paganelli, MD, Giovanni Martinelli, MD

Blood (2006) 108 (11): 2771.

https://doi.org/10.1182/blood.V108.11.2771.2771

Published: 2006

Journal Articles

Tissue Microarray (TMA) Study in DLBC Lymphomas (DLBCL): Could the Extranodal Origin Affect the Prognostic Impact of the Analysis?.

Daniele Laszlo, MD, Giancarlo Pruneri, MD, Giovanna Andreola, MD, Davide Radice, ST, Liliana Calabrese, DM, Alessandra Alietti, MD, Alberto Agazzi, MD, Anna Vanazzi, MD, Giovanni Martinelli, MD

Blood (2006) 108 (11): 2037.

https://doi.org/10.1182/blood.V108.11.2037.2037

Published: 2006

Journal Articles

High Dose Chemotherapy with Autologous Stem Cell Support Is Effective in Resistant and Refractory Hodgkin Lymphoma. A Single Center Analysis.

Emilia Cocorocchio, MD, Fedro Peccatori, MD, Simona Bassi, MD, Federica Gigli, MD, Davide Radice, Giancarlo Pruneri, MD, Cristina Rabascio, Liliana Calabrese, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5506.

https://doi.org/10.1182/blood.V106.11.5506.5506

Published: 2005

Journal Articles

Inhibition of the B Cell Associated Tyrosine Kinase SYK as a Potential Therapeutic Target in Aggressive Lymphomas.

Francesco Bertoni, MD, Andrea Rinaldi, B.Sc, Anna Sasso, Silvia Uccella, MD, Vittoria Martin, B. Sc, Sara Napoli, B. Sc, Giancarlo Pruneri, MD, Emanuele Zucca, MD, Carlo Capella, MD, Carlo V. Catapano, MD, PhD, Maria Grazia Tibiletti, B.Sc, Franco Cavalli, MD

Blood (2005) 106 (11): 1469.

https://doi.org/10.1182/blood.V106.11.1469.1469

Published: 2005

Journal Articles

Gene Expression Profiling of Plasma Cell Dyscrasias: The Role of IGH Translocations in the Heterogeneity of Multiple Myeloma.

Antonino Neri, MD, Michela Mattioli, PhD, Luca Agnelli, PhD, Sonia Fabris, PhD, Luca Baldini, MD, Fortunato Morabito, MD, Silvio Bicciato, PhD, Donata Verdelli, PhD, Daniela Intini, PhD, Lucia Nobili, PhD, Lilla Cro, PhD, Giancarlo Pruneri, MD, Vincenzo Callea, MD, Caterina Stelitano, MD, Luigia Lombardi, PhD

Blood (2004) 104 (11): 4845.

https://doi.org/10.1182/blood.V104.11.4845.4845

Published: 2004

NARROW

Rituximab and Chlorambucil as Front-Line Treatment in Untreated Follicular Lymphoma: a Combination with a Durable Response and Low Toxicity Profile.

Continuous Immuno-Chemotherapy Followed by High Dose and Autologous Cell Transplantation May Improve the Event-Free-Survival in Mantle Cell Lymphoma Patients. Experience at the European Institute of Oncology in Milan.

Efficacy of 90Y-Ibritumomab Tiuxetan in Marginal-Zone Lymphoma (MZL).

Combined VBM Chemotherapy and Involved Field (IF) Radiotherapy in Early Stage Hodgkin’s Lymphoma (HL): A Single Centre Experience.

Efficacy of 90 Y-Ibritumomab Tiuxetan (Zevalin) in Refractory or Relapsed MALT Gastric Non Hodgkin’s Lymphoma.

Tissue Microarray (TMA) Study in DLBC Lymphomas (DLBCL): Could the Extranodal Origin Affect the Prognostic Impact of the Analysis?.

High Dose Chemotherapy with Autologous Stem Cell Support Is Effective in Resistant and Refractory Hodgkin Lymphoma. A Single Center Analysis.

Inhibition of the B Cell Associated Tyrosine Kinase SYK as a Potential Therapeutic Target in Aggressive Lymphomas.

Gene Expression Profiling of Plasma Cell Dyscrasias: The Role of IGH Translocations in the Heterogeneity of Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only